HRP940179B1 - Phenoxyphenylacetic acid derivatives - Google Patents
Phenoxyphenylacetic acid derivativesInfo
- Publication number
- HRP940179B1 HRP940179B1 HR940179A HRP940179A HRP940179B1 HR P940179 B1 HRP940179 B1 HR P940179B1 HR 940179 A HR940179 A HR 940179A HR P940179 A HRP940179 A HR P940179A HR P940179 B1 HRP940179 B1 HR P940179B1
- Authority
- HR
- Croatia
- Prior art keywords
- acid derivatives
- phenoxyphenylacetic acid
- phenoxyphenylacetic
- derivatives
- vasospasm
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/51—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
- C07C59/70—Ethers of hydroxy-acetic acid, e.g. substitutes on the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
- C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/64—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3445593A | 1993-03-19 | 1993-03-19 | |
US19746794A | 1994-02-24 | 1994-02-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP940179A2 HRP940179A2 (en) | 1998-02-28 |
HRP940179B1 true HRP940179B1 (en) | 2000-10-31 |
Family
ID=26710968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR940179A HRP940179B1 (en) | 1993-03-19 | 1994-03-18 | Phenoxyphenylacetic acid derivatives |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0617001B1 (es) |
JP (1) | JPH08508034A (es) |
KR (1) | KR960700992A (es) |
CN (1) | CN1119434A (es) |
AT (1) | ATE189217T1 (es) |
AU (1) | AU679710B2 (es) |
CA (1) | CA2119051A1 (es) |
CZ (1) | CZ233595A3 (es) |
DE (1) | DE69422742T2 (es) |
DK (1) | DK0617001T3 (es) |
ES (1) | ES2141197T3 (es) |
FI (1) | FI954404A0 (es) |
GR (1) | GR3032643T3 (es) |
HR (1) | HRP940179B1 (es) |
HU (1) | HU217028B (es) |
IL (1) | IL108944A0 (es) |
NO (1) | NO953672L (es) |
NZ (1) | NZ263414A (es) |
PL (1) | PL175786B1 (es) |
PT (1) | PT617001E (es) |
RU (1) | RU2139273C1 (es) |
SK (1) | SK114795A3 (es) |
WO (1) | WO1994021590A1 (es) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6124343A (en) * | 1919-01-27 | 2000-09-26 | Rhone-Poulenc Rorer Limited | Substituted phenyl compounds with a substituent having a thienyl ring |
US5514696A (en) * | 1992-05-06 | 1996-05-07 | Bristol-Myers Squibb Co. | Phenyl sulfonamide endothelin antagonists |
US5686478A (en) * | 1993-07-20 | 1997-11-11 | Merck & Co. Inc. | Endothelin antagonists |
CA2195758A1 (en) * | 1994-08-08 | 1996-02-22 | Scott W. Bagley | Phenoxyphenylacetic acid derivatives |
US5612359A (en) * | 1994-08-26 | 1997-03-18 | Bristol-Myers Squibb Company | Substituted biphenyl isoxazole sulfonamides |
US5538991A (en) * | 1994-09-14 | 1996-07-23 | Merck & Co., Inc. | Endothelin antagonists bearing 5-membered heterocyclic amides |
US5559135A (en) * | 1994-09-14 | 1996-09-24 | Merck & Co., Inc. | Endothelin antagonists bearing pyridyl amides |
DE69609812D1 (de) * | 1995-01-27 | 2000-09-21 | Rhone Poulenc Rorer Ltd | Substituierte phenylverbindungen als endothelinantagoniste |
US5780473A (en) * | 1995-02-06 | 1998-07-14 | Bristol-Myers Squibb Company | Substituted biphenyl sulfonamide endothelin antagonists |
US5760038A (en) * | 1995-02-06 | 1998-06-02 | Bristol-Myers Squibb Company | Substituted biphenyl sulfonamide endothelin antagonists |
DE19527568A1 (de) | 1995-07-28 | 1997-01-30 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
US5846990A (en) * | 1995-07-24 | 1998-12-08 | Bristol-Myers Squibb Co. | Substituted biphenyl isoxazole sulfonamides |
DE19528418A1 (de) * | 1995-08-02 | 1997-02-06 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
DE19530032A1 (de) * | 1995-08-16 | 1997-02-20 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
DE19537548A1 (de) * | 1995-10-09 | 1997-04-10 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
JPH09124620A (ja) * | 1995-10-11 | 1997-05-13 | Bristol Myers Squibb Co | 置換ビフェニルスルホンアミドエンドセリン拮抗剤 |
US5688974A (en) * | 1995-12-12 | 1997-11-18 | Merck & Co., Inc. | Process for the preparation of an endothelin antagonist |
CA2238976A1 (en) * | 1995-12-12 | 1997-06-19 | Merck & Co., Inc. | Process for the preparation of an endothelin antagonist |
US5977117A (en) * | 1996-01-05 | 1999-11-02 | Texas Biotechnology Corporation | Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin |
US5847008A (en) * | 1996-02-02 | 1998-12-08 | Merck & Co., Inc. | Method of treating diabetes and related disease states |
ATE293963T1 (de) * | 1996-02-02 | 2005-05-15 | Merck & Co Inc | Verfahren zur behandlung von diabetes und verwandter krankheitszustände. |
US6090836A (en) * | 1996-02-02 | 2000-07-18 | Merck & Co., Inc. | Benzisoxazole-derived antidiabetic compounds |
US5859051A (en) * | 1996-02-02 | 1999-01-12 | Merck & Co., Inc. | Antidiabetic agents |
US6020382A (en) * | 1996-02-02 | 2000-02-01 | Merck & Co., Inc. | Method of treating diabetes and related disease states |
US5856507A (en) * | 1997-01-21 | 1999-01-05 | Bristol-Myers Squibb Co. | Methods for the preparation of biphenyl isoxazole sulfonamides |
SG87053A1 (en) | 1996-02-20 | 2002-03-19 | Bristol Myers Squibb Co | High melt polymorth of the compound n-(3,4-dimethyl-5-isoxazolyl)-4'- (2-oxazolyl) [1,1'-biphenyl]-2-sulfonamide |
US5939446A (en) * | 1996-04-09 | 1999-08-17 | Bristol-Myers Squibb Co. | Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists |
GB9609641D0 (en) * | 1996-05-09 | 1996-07-10 | Pfizer Ltd | Compounds useful in therapy |
DE19653024A1 (de) * | 1996-12-19 | 1998-06-25 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
US6090839A (en) * | 1996-12-23 | 2000-07-18 | Merck & Co., Inc. | Antidiabetic agents |
US6160000A (en) * | 1996-12-23 | 2000-12-12 | Merck & Co., Inc. | Antidiabetic agents based on aryl and heteroarylacetic acids |
TW536540B (en) * | 1997-01-30 | 2003-06-11 | Bristol Myers Squibb Co | Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe |
WO1998033781A1 (en) * | 1997-01-30 | 1998-08-06 | Bristol-Myers Squibb Company | Method for preventing or treating low renin hypertension by administering an endothelin antagonist |
DE19710831A1 (de) * | 1997-03-15 | 1998-09-17 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
CZ299741B6 (cs) | 1997-09-26 | 2008-11-05 | Abbott Gmbh & Co. Kg | Kombinace endotelinového antagonisty a RAS inhibitoru a její použití, farmaceutický prostredek s jejím obsahem a zpusob výroby tohoto prostredku |
DE19743143A1 (de) | 1997-09-30 | 1999-04-01 | Knoll Ag | Pharmazeutische Kombinationspräparate |
GB9722287D0 (en) * | 1997-10-22 | 1997-12-17 | Pfizer Ltd | Compounds useful in therapy |
DE19747788A1 (de) | 1997-10-29 | 1999-05-06 | Basf Ag | Substituierte 2-(2'-Pyridyloxy)phenylessigsäureamide, ihre Herstellung und Verwendung, sowie sie enthaltende Mittel |
AU3011299A (en) * | 1998-03-23 | 1999-10-18 | Merck & Co., Inc. | Combination therapy for the treatment of benign prostatic hyperplasia |
US6410554B1 (en) | 1998-03-23 | 2002-06-25 | Merck & Co., Inc. | Combination therapy for the treatment of benign prostatic hyperplasia |
CN1295477A (zh) | 1998-03-31 | 2001-05-16 | 田边制药株式会社 | 排尿困难的预防或治疗剂 |
US6017918A (en) * | 1998-08-06 | 2000-01-25 | Warner-Lambert Company | Phenyl glycine compounds and methods of treating atherosclerosis and restenosis |
US6284795B1 (en) * | 1998-09-04 | 2001-09-04 | Warner-Lambert Company | Sulfonamide compounds and methods of treating atherosclerosis and restenosis |
MXPA01009362A (es) | 1999-03-19 | 2002-06-04 | Squibb Bristol Myers Co | Metodos para la preparacion de bifenil isoxazol sulfonamidas. |
AU1073001A (en) * | 1999-10-12 | 2001-04-23 | Basf Aktiengesellschaft | Method of identifying inhibitors of cdc25 |
AU2002217999A1 (en) | 2000-11-01 | 2002-05-15 | Cor Therapeutics, Inc. | Process for the production of 4-quinazolinylpiperazin-1-carboxylic acid phenylamides |
US7091230B2 (en) | 2001-02-09 | 2006-08-15 | Merck & Co., Inc. | 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
MXPA04009040A (es) * | 2002-03-20 | 2005-01-25 | Metabolex Inc | Acidos fenilaceticos sustituidos. |
US8614236B2 (en) | 2006-12-12 | 2013-12-24 | University Of Washington | Methods of treating pulmonary disease using acetazolamide and structurally related derivatives |
CN101042381B (zh) * | 2007-04-28 | 2014-01-08 | 长春迈灵生物工程有限公司 | 一种地舍平的检测方法 |
CN102822152A (zh) * | 2009-11-09 | 2012-12-12 | 诺瓦德克斯制药股份有限公司 | 新颖的1,3-噁唑烷化合物及其作为肾素抑制剂的用途 |
JP5830534B2 (ja) | 2010-07-09 | 2015-12-09 | ファイザー・リミテッドPfizer Limited | 化合物 |
EP2593433B1 (en) | 2010-07-12 | 2014-11-26 | Pfizer Limited | N-sulfonylbenzamides as inhibitors of voltage-gated sodium channels |
CA2801032A1 (en) | 2010-07-12 | 2012-01-19 | Pfizer Limited | N-sulfonylbenzamide derivatives useful as voltage gated sodium channel inhibitors |
WO2012007868A2 (en) | 2010-07-12 | 2012-01-19 | Pfizer Limited | Chemical compounds |
JP2013536165A (ja) | 2010-07-12 | 2013-09-19 | ファイザー・リミテッド | 痛みの処置のためのnav1.7阻害薬としてのスルホンアミド誘導体 |
JP2013531030A (ja) | 2010-07-12 | 2013-08-01 | ファイザー・リミテッド | 電位開口型ナトリウムチャネルの阻害剤としてのn−スルホニルベンズアミド |
EP2655331A1 (en) | 2010-12-23 | 2013-10-30 | Pfizer Inc | Glucagon receptor modulators |
GEP20156351B (en) | 2011-02-08 | 2015-08-25 | Pfizer | Glucagon receptor modulator |
KR20140023441A (ko) | 2011-07-22 | 2014-02-26 | 화이자 인코포레이티드 | 퀴놀린일 글루카곤 수용체 조절제 |
EP2791108B1 (en) | 2011-12-15 | 2016-07-27 | Pfizer Limited | Sulfonamide derivatives |
CN111825564B (zh) * | 2020-09-21 | 2020-12-29 | 西藏甘露藏药股份有限公司 | 一种从渣驯中提取的化合物、制备方法及其用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1408738A (fr) * | 1964-04-29 | 1965-08-20 | Nobel Bozel | Nouveaux dérivés de l'acide bis(hydroxy-4-phényl)-acétique |
US4748272A (en) * | 1986-08-01 | 1988-05-31 | Rorer Pharmaceutical Corp. | Phenoxyphenylacetates for use as potential modulators of arichidonic acid pathways |
JPS63122605A (ja) * | 1986-11-10 | 1988-05-26 | Tokuyama Soda Co Ltd | 除草剤組成物 |
-
1994
- 1994-03-10 ES ES94301728T patent/ES2141197T3/es not_active Expired - Lifetime
- 1994-03-10 DE DE69422742T patent/DE69422742T2/de not_active Expired - Fee Related
- 1994-03-10 PT PT94301728T patent/PT617001E/pt unknown
- 1994-03-10 AT AT94301728T patent/ATE189217T1/de not_active IP Right Cessation
- 1994-03-10 EP EP94301728A patent/EP0617001B1/en not_active Expired - Lifetime
- 1994-03-10 DK DK94301728T patent/DK0617001T3/da active
- 1994-03-11 IL IL10894494A patent/IL108944A0/xx unknown
- 1994-03-15 CA CA002119051A patent/CA2119051A1/en not_active Abandoned
- 1994-03-17 SK SK1147-95A patent/SK114795A3/sk unknown
- 1994-03-17 CZ CZ952335A patent/CZ233595A3/cs unknown
- 1994-03-17 NZ NZ263414A patent/NZ263414A/en unknown
- 1994-03-17 CN CN94191512A patent/CN1119434A/zh active Pending
- 1994-03-17 JP JP6521226A patent/JPH08508034A/ja not_active Withdrawn
- 1994-03-17 WO PCT/US1994/002871 patent/WO1994021590A1/en not_active Application Discontinuation
- 1994-03-17 HU HU9502725A patent/HU217028B/hu not_active IP Right Cessation
- 1994-03-17 RU RU95121625A patent/RU2139273C1/ru active
- 1994-03-17 PL PL94310661A patent/PL175786B1/pl unknown
- 1994-03-18 AU AU57878/94A patent/AU679710B2/en not_active Ceased
- 1994-03-18 HR HR940179A patent/HRP940179B1/xx not_active IP Right Cessation
-
1995
- 1995-09-18 FI FI954404A patent/FI954404A0/fi unknown
- 1995-09-18 NO NO953672A patent/NO953672L/no not_active Application Discontinuation
- 1995-09-18 KR KR1019950704018A patent/KR960700992A/ko not_active Application Discontinuation
-
2000
- 2000-02-11 GR GR20000400340T patent/GR3032643T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0617001A1 (en) | 1994-09-28 |
HU9502725D0 (en) | 1995-11-28 |
HUT73658A (en) | 1996-09-30 |
WO1994021590A1 (en) | 1994-09-29 |
HRP940179A2 (en) | 1998-02-28 |
SK114795A3 (en) | 1996-06-05 |
EP0617001B1 (en) | 2000-01-26 |
KR960700992A (ko) | 1996-02-24 |
DE69422742D1 (de) | 2000-03-02 |
CN1119434A (zh) | 1996-03-27 |
ATE189217T1 (de) | 2000-02-15 |
RU2139273C1 (ru) | 1999-10-10 |
NZ263414A (en) | 1997-09-22 |
AU679710B2 (en) | 1997-07-10 |
PT617001E (pt) | 2000-06-30 |
DK0617001T3 (da) | 2000-04-17 |
DE69422742T2 (de) | 2000-08-17 |
FI954404A (fi) | 1995-09-18 |
CA2119051A1 (en) | 1994-09-20 |
AU5787894A (en) | 1994-09-22 |
HU217028B (hu) | 1999-11-29 |
IL108944A0 (en) | 1994-06-24 |
NO953672D0 (no) | 1995-09-18 |
CZ233595A3 (en) | 1996-01-17 |
PL310661A1 (en) | 1995-12-27 |
FI954404A0 (fi) | 1995-09-18 |
PL175786B1 (pl) | 1999-02-26 |
GR3032643T3 (en) | 2000-06-30 |
JPH08508034A (ja) | 1996-08-27 |
NO953672L (no) | 1995-11-17 |
ES2141197T3 (es) | 2000-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT73658A (en) | Phenoxyphenylacetic acid derivatives | |
MX9308191A (es) | Antagonistas de endotelina. | |
CA2080705A1 (en) | Substituted pyrimidines | |
AP9701004A0 (en) | Low molecular weight bicyclic thrombin inhibitors. | |
CA2297911A1 (en) | Substituted 6-phenylphenanthridines | |
CA2382406A1 (en) | Substituted 2-arylbenzazole compounds and their use as antitumour agents | |
CA2133439A1 (en) | Compounds useful for treating allergic and inflammatory diseases | |
WO2000071516A3 (en) | INHIBITORS OF FACTOR Xa | |
CA2062837A1 (en) | 8-substituted purines as selective adenosine receptor agents | |
CH692199A8 (fr) | Composes pyridiques et compositions pharmaceutique | |
PL368529A1 (en) | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors | |
ATE195948T1 (de) | Endothelinantagonisten | |
DE69528711T2 (de) | Chinazolinen als inhibitoren des endothelin konvertierenden enzyme | |
PL326236A1 (en) | Novel compounds - derivatives of sulphonylpyrimidine exhibiting anticarcinogenous effect and method of obtaining them | |
CA2264005A1 (en) | Piperazino derivatives as neurokinin antagonists | |
CA2014062A1 (en) | Pyridine derivatives | |
NO944013L (no) | Endothelin-antagonister II | |
BG104022A (en) | New beta-amino and beta-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor antagonists | |
HK1083492A1 (en) | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors | |
CA2128876A1 (en) | Triazolopyrimidine derivatives as angiotensin ii receptor antagonists | |
MX12192A (es) | Composicion farmaceutica para reducir o impedir las arritmias | |
KR100344711B1 (es) | ||
MX9704594A (es) | Peptidos heterociclicos de la ceto-arginina, como inhibidores de la trombina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
B1PR | Patent granted | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20010318 Year of fee payment: 8 |
|
PBON | Lapse due to non-payment of renewal fee |
Effective date: 20020319 |